Global Transfection Technologies Market 2022-2026

Description

List of Tables

Technavio has been monitoring the transfection technologies market and it is poised to grow by $526.14 mn during 2022-2026, accelerating at a CAGR of 9.05% during the forecast period. Our report on the transfection technologies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for monoclonal antibodies, availability of innovative products, and high demand for biopharmaceuticals.

The transfection technologies market analysis includes the end-user segment and geographic landscape.

Technavio's transfection technologies market is segmented as below:

By End-user

Pharmaceutical and biotechnology companies
Contract research organizations
Academic and research institutes

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the increased use of dual-reporter assays and co-transfection experiments as one of the prime reasons driving the transfection technologies market growth during the next few years. Also, optimization of transfection efficiency and growth in initiatives for molecular research and related activities will lead to sizable demand in the market.

Technavio presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters. Our report on the transfection technologies market covers the following areas:

Transfection technologies market sizing
Transfection technologies market forecast
Transfection technologies market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transfection technologies market vendors that include Altogen Biosystems, Bio Rad Laboratories Inc., Biontex Laboratories GmbH, Boca Scientific Inc., F. Hoffmann La Roche Ltd., GENLANTIS, Inovio Pharmaceuticals Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, POLYPLUS TRANSFECTION S.A, Promega Corp., PromoCell GmbH, QIAGEN NV, SignaGen Laboratories, Takara Holdings Inc, and Thermo Fisher Scientific Inc. Also, the transfection technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR74402

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

5.1 Market segments
Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
5.2 Comparison by End-user
Exhibit 26: Chart on Comparison by End-user
Exhibit 27: Data Table on Comparison by End-user
5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
Exhibit 28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
5.4 Contract research organizations - Market size and forecast 2021-2026
Exhibit 32: Chart on Contract research organizations - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Contract research organizations - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Contract research organizations - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Contract research organizations - Year-over-year growth 2021-2026 (%)
5.5 Academic and research institutes - Market size and forecast 2021-2026
Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by End-user
Exhibit 40: Market opportunity by End-user ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.5 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 China - Market size and forecast 2021-2026
Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
7.9 Japan - Market size and forecast 2021-2026
Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 India - Market size and forecast 2021-2026
Exhibit 82: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on India - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Bio Rad Laboratories Inc.
Exhibit 93: Bio Rad Laboratories Inc. - Overview
Exhibit 94: Bio Rad Laboratories Inc. - Business segments
Exhibit 95: Bio Rad Laboratories Inc. - Key news
Exhibit 96: Bio Rad Laboratories Inc. - Key offerings
Exhibit 97: Bio Rad Laboratories Inc. - Segment focus
10.4 Lonza Group Ltd.
Exhibit 98: Lonza Group Ltd. - Overview
Exhibit 99: Lonza Group Ltd. - Business segments
Exhibit 100: Lonza Group Ltd. - Key news
Exhibit 101: Lonza Group Ltd. - Key offerings
Exhibit 102: Lonza Group Ltd. - Segment focus
10.5 Merck KGaA
Exhibit 103: Merck KGaA - Overview
Exhibit 104: Merck KGaA - Business segments
Exhibit 105: Merck KGaA - Key news
Exhibit 106: Merck KGaA - Key offerings
Exhibit 107: Merck KGaA - Segment focus
10.6 Mirus Bio LLC
Exhibit 108: Mirus Bio LLC - Overview
Exhibit 109: Mirus Bio LLC - Product / Service
Exhibit 110: Mirus Bio LLC - Key news
Exhibit 111: Mirus Bio LLC - Key offerings
10.7 OZ Biosciences
Exhibit 112: OZ Biosciences - Overview
Exhibit 113: OZ Biosciences - Product / Service
Exhibit 114: OZ Biosciences - Key offerings
10.8 POLYPLUS TRANSFECTION S.A
Exhibit 115: POLYPLUS TRANSFECTION S.A - Overview
Exhibit 116: POLYPLUS TRANSFECTION S.A - Product / Service
Exhibit 117: POLYPLUS TRANSFECTION S.A - Key news
Exhibit 118: POLYPLUS TRANSFECTION S.A - Key offerings
10.9 Promega Corp.
Exhibit 119: Promega Corp. - Overview
Exhibit 120: Promega Corp. - Product / Service
Exhibit 121: Promega Corp. - Key offerings
10.10 QIAGEN NV
Exhibit 122: QIAGEN NV - Overview
Exhibit 123: QIAGEN NV - Product / Service
Exhibit 124: QIAGEN NV - Key news
Exhibit 125: QIAGEN NV - Key offerings
10.11 SignaGen Laboratories
Exhibit 126: SignaGen Laboratories - Overview
Exhibit 127: SignaGen Laboratories - Product / Service
Exhibit 128: SignaGen Laboratories - Key offerings
10.12 Thermo Fisher Scientific Inc.
Exhibit 129: Thermo Fisher Scientific Inc. - Overview
Exhibit 130: Thermo Fisher Scientific Inc. - Business segments
Exhibit 131: Thermo Fisher Scientific Inc. - Key news
Exhibit 132: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 133: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 134: Inclusions checklist
Exhibit 135: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 136: Currency conversion rates for US$
11.4 Research methodology
Exhibit 137: Research methodology
Exhibit 138: Validation techniques employed for market sizing
Exhibit 139: Information sources
11.5 List of abbreviations
Exhibit 140: List of abbreviations
- growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
- product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.